Natriumcromoglicaat Allergieoogdruppels Htp (Sodium Cromoglicate)

Sodium cromoglicate stabilizes mast cells in the conjunctiva, preventing them from releasing histamine, leukotrienes and other inflammatory mediators. By blocking this degranulation cascade, it reduces vascular leakage and nerve irritation that cause the typical allergic eye symptoms.

The dosing regimen for this product is determined by the prescribing ophthalmologist or healthcare professional based on the severity of the allergy, patient age and response to therapy. Patients should follow the specific instructions provided by their prescriber.

Safety data for sodium cromoglicate eye drops in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To request a supply, visit the product page on gnhindia.com, enter the required quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike antihistamine eye drops that block histamine receptors, sodium cromoglicate works upstream by stabilizing mast cells, preventing the release of multiple mediators. This mechanism can provide broader symptom control, especially for patients who do not respond fully to antihistamines alone.

The eye‑drop bottles should be stored at room temperature, below 25 °C, in their original packaging. Protect them from direct sunlight, excessive heat and moisture to maintain product stability.

The drops are applied topically to the affected eye(s) as directed by the prescriber. Typically, one to two drops are instilled per eye, with the eyelids gently closed for a few seconds to allow absorption. Avoid touching the tip of the bottle to the eye or any surface.

Although rare, serious adverse events can include severe allergic reactions such as swelling, rash, anaphylaxis, corneal ulceration, sudden vision loss or persistent eye pain. Patients should seek immediate medical attention if any of these symptoms develop.

Individuals with a known hypersensitivity to sodium cromoglicate or any excipients in the formulation should avoid using the product. It is also contraindicated in patients who have active ocular infections without appropriate antimicrobial therapy.